Literature DB >> 4031949

Agyria (lissencephaly) with anomalous pyramidal crossing. Case report and review of literature.

U Roessmann, A Hori.   

Abstract

A case of agyria (lissencephaly) with a highly unusual course of the corticospinal tract at the crossing and in the spinal cord is described. Published cases of agyria (lissencephaly) are reviewed with special attention to the cortical fiber system and organization of the necortex, and their implications for possible pathogenetic mechanisms. The problem of nomenclature is discussed.

Entities:  

Mesh:

Year:  1985        PMID: 4031949     DOI: 10.1016/0022-510x(85)90146-7

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  6 in total

1.  Inverted neurons in agyria. A Golgi study of a case with abnormal chromosome 17.

Authors:  C Bordarier; O Robain; M O Rethoré; O Dulac; C Dhellemes
Journal:  Hum Genet       Date:  1986-08       Impact factor: 4.132

Review 2.  A review of the morphology of spinal cord malformations and their relation to neuro-embryology.

Authors:  A Hori
Journal:  Neurosurg Rev       Date:  1993       Impact factor: 3.042

Review 3.  Development and malformations of the human pyramidal tract.

Authors:  H J ten Donkelaar; M Lammens; P Wesseling; A Hori; A Keyser; J Rotteveel
Journal:  J Neurol       Date:  2004-12       Impact factor: 4.849

Review 4.  Pathophysiological Heterogeneity of the BBSOA Neurodevelopmental Syndrome.

Authors:  Michele Bertacchi; Chiara Tocco; Christian P Schaaf; Michèle Studer
Journal:  Cells       Date:  2022-04-08       Impact factor: 7.666

5.  Abnormal course of spinal posterior roots and tracts associated with brain malformations. Sensory pathway malformation.

Authors:  A Hori
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

6.  Spectrum of clinical features and neuroimaging findings in acute cerebral infarction patients with unusual ipsilateral motor impairment- a series of 22 cases.

Authors:  Zhe-Ren Tan; Chen Zhang; Fa-Fa Tian
Journal:  BMC Neurol       Date:  2019-11-12       Impact factor: 2.474

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.